肥胖人群中代谢综合征组分与多发性神经病的关联
这项横断面观察研究纳入102例肥胖参与者和53例瘦对照,按血糖状态分层发现多发性神经病患病率在瘦对照为3.8%、肥胖血糖正常者为11.1%、肥胖糖尿病前期者为29%、肥胖糖尿病者为34.6%(趋势P<.01)。多变量模型中年龄、糖尿病和腰围与神经病显著相关,糖尿病前期未达显著。
要点
- 肥胖者即使血糖正常,多发性神经病患病率仍高于瘦对照。
- 多发性神经病患病率随血糖状态恶化而升高,趋势检验P<.01。
- 年龄、糖尿病和腰围是多发性神经病的显著相关因素。
核心结论
- 肥胖个体中多发性神经病患病率高,即使血糖正常者亦如此。
- 糖尿病、糖尿病前期和肥胖可能是该神经病的代谢驱动因素。
研究设计与样本
- 肥胖参与者来自体重管理项目,瘦对照来自研究网站。
- 共纳入102例肥胖参与者和53例瘦对照。
- 采用Mantel-Haenszel χ2检验分析患病率趋势,Logistic回归建模。
主要发现
- 多发性神经病患病率:瘦对照3.8%(n=2),肥胖血糖正常者11.1%(n=5),肥胖糖尿病前期者29%(n=9),肥胖糖尿病者34.6%(n=9),趋势P<.01。
- 多变量模型中年龄OR 1.09(95%CI 1.02-1.16)与神经病显著相关。
- 糖尿病OR 4.90(95%CI 1.06-22.63)与神经病显著相关。
- 腰围OR 1.24(95%CI 1.00-1.55)与神经病显著相关。
- 糖尿病前期OR 3.82(95%CI 0.95-15.41)与神经病无显著关联。
关键数值与推荐
- 代谢综合征组分依据美国国家胆固醇教育计划成人治疗组III定义。
- 血糖状态依据糖尿病诊断与分类专家委员会定义。
- 主要结局采用多伦多共识定义的很可能多发性神经病。
临床怎么用
- 对肥胖患者应关注多发性神经病风险,即使血糖正常也需评估。
- 腰围和年龄可作为肥胖患者神经病风险评估的参考因素。
- 糖尿病前期与神经病的关联在本研究中未达显著,需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Past studies have shown an association between metabolic syndrome and polyneuropathy, but the precise components that drive this association remain unclear. OBJECTIVES: To determine the prevalence of polyneuropathy stratified by glycemic status in well-characterized obese and lean participants and investigate the association of specific components of metabolic syndrome with polyneuropathy. DESIGN, SETTING, AND PARTICIPANTS: We performed a cross-sectional, observational study from November 1, 2010, to December 31, 2014, in obese participants (body mass index [calculated as weight in kilograms divided by height in meters squared] of 35 or more with no comorbid conditions or 32 or more with at least 1 comorbid condition) from a weight management program and lean controls from a research website. The prevalence of neuropathy, stratified by glycemic status, was determined, and a Mantel-Haenszel χ2 test was used to investigate for a trend. Logistic regression was used to model the primary outcome of polyneuropathy as a function of the components of metabolic syndrome after adjusting for demographic factors. Participants also completed quantitative sudomotor axon reflex testing, quantitative sensory testing, the neuropathy-specific Quality of Life in Neurological Disorders instrument, and the short-form McGill Pain Questionnaire. EXPOSURES: Components of metabolic syndrome (as defined by the National Cholesterol Education Program Adult Treatment Panel III), including glycemic status (as defined by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus). MAIN OUTCOMES AND MEASURES: Toronto consensus definition of probable polyneuropathy. Secondary outcomes included intraepidermal nerve fiber density and nerve conduction study parameters. RESULTS: We enrolled 102 obese participants (mean [SD] age, 52.9 [10.2] years; 48 men and 54 women; 45 with normoglycemia [44.1%], 31 with prediabetes [30.4%], and 26 with type 2 diabetes [25.5%]) and 53 lean controls (mean [SD] age, 48.5 [9.9] years; 16 men and 37 women). The prevalence of polyneuropathy was 3.8% in lean controls (n = 2), 11.1% in the obese participants with normoglycemia (n = 5), 29% in the obese participants with prediabetes (n = 9), and 34.6% in the obese participants with diabetes (n = 9) (P < .01 for trend). Age (odds ratio, 1.09; 95% CI, 1.02-1.16), diabetes (odds ratio, 4.90; 95% CI, 1.06-22.63), and waist circumference (odds ratio, 1.24; 95% CI, 1.00-1.55) were significantly associated with neuropathy in multivariable models. Prediabetes (odds ratio, 3.82; 95% CI, 0.95-15.41) was not significantly associated with neuropathy. CONCLUSIONS AND RELEVANCE: The prevalence of polyneuropathy is high in obese individuals, even those with normoglycemia. Diabetes, prediabetes, and obesity are the likely metabolic drivers of this neuropathy. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT02689661.
引用
- Callaghan BC, Xia R, Reynolds E, et al. Association Between Metabolic Syndrome Components and Polyneuropathy in an Obese Population. JAMA Neurol. 2016. PMID: 27802497. doi:10.1001/jamaneurol.2016.3745
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。